AstraZeneca PLC is among the top cancer stocks favored by hedge funds. Cancer remains a leading global cause of death, prompting innovative strategies like immunotherapy and mRNA treatments. Companies are investing in radiopharmaceuticals for targeted cancer treatment, potentially generating billions in revenue.